Burning Rock Biotech passed all shareholder resolutions at 2024 annual general meeting.

From GlobeNewswire: 2024-12-31 04:56:17

Burning Rock Biotech Limited (NASDAQ: BNR) announced that all shareholder resolutions proposed at the 2024 annual general meeting were passed. This includes the appointment of Ernst & Young Hua Ming LLP as auditor for the fiscal year ending December 31, 2024, re-election of directors Yusheng Han and Gang Lu, and authorization for directors to take necessary actions. Burning Rock focuses on next generation sequencing technology for precision oncology, offering therapy selection testing for late-stage cancer patients and early cancer detection. For more information, visit ir.brbiotech.com. Contact [email protected] for inquiries.



Read more at GlobeNewswire: Burning Rock Announces Results of 2024 Annual General